Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2025 (5)
  • 2024 (5)
  • 2023 (2)
  • 2022 (1)

Subject

  • Synthetic drugs (110)
  • Drug Trafficking (96)
  • Arrests/Convictions - Major (42)
  • Guns/Weapons (26)
  • Seizures (Drugs/Property) (22)
  • Guilty Plea (21)
  • Fake Pills (13)
  • Prescription Drugs (12)
  • Overdose (10)
  • Gangs (9)
  • Major Law Enforcement Operation (9)
  • OCDETF/Task Force (9)
  • Money Laundering (7)
  • Pharmaceuticals/Pharmacists/Physicians (7)
  • Take Back Day (4)
  • Task Forces/Task Force Officers (3)
  • Dark Web- Internet Trafficking (2)
  • Asset Forfeiture (1)
  • Congressional Affairs (1)
  • Fentanyl Awareness (1)
  • HIDTA (1)
  • Outreach/Drug Prevention (1)
  • Terrorism (1)
  • Diversion Division (7)
  • Extraditions (6)

Drug Name

  • Fentanyl (5)
  • Cocaine (2)
  • Heroin (2)
  • Methamphetamine (1)
  • Opioids (1)

Field Division

  • Washington, DC (37)
  • New England (33)
  • New York (28)
  • Seattle (24)
  • Chicago (20)
  • Houston (19)
  • New Jersey (16)
  • Atlanta (14)
  • Miami (13)
  • Sede (12)
  • El Paso (10)
  • Dallas (9)
  • San Diego (9)
  • New Orleans (8)
  • St. Louis (7)
  • Phoenix (5)
  • Rocky Mountain (5)
  • Los Angeles (3)
  • Omaha (3)
  • Louisville (2)
  • Detroit (1)
  • San Francisco (13)
Clear All Results
PRESS RELEASE

Digital Health Company Cofounder/CEO and Clinical President Convicted in $100M Adderall Distribution and Health Care Fraud Scheme

Noviembre 20, 2025
SAN FRANCISCO – United States Drug Enforcement Administration (“DEA”) San Francisco Division Special Agent in Charge Bob Beris, DEA New York Division Special Agent in Charge Frank Tarentino, along with our law enforcement partners Homeland Security Investigations (“HSI”) , U.S. Department of Health and Human Services – Office of Inspector...
Noviembre 20, 2025
PRESS RELEASE

Communities Nationwide Join DEA and its Partners to Safely Dispose of 571,000 pounds of Unwanted Medications

Noviembre 03, 2025
SAN FRANCISCO – On October 25, 2025, DEA joined 4,263 law enforcement agencies across the country who came together for the 29th National Prescription Drug Take Back Day. At 4,317 collection sites nationwide, Take Back events removed 571,054 pounds of unneeded and expired medications from home medicine cabinets to prevent...
Noviembre 03, 2025
PRESS RELEASE

Sacramento Doctor Agrees to Pay $125,000 for Controlled Substances Act Violations at Sutter Imaging Capitol Pavilion

Junio 04, 2025
SACRAMENTO, Calif. — Philip Yen, M.D. has agreed to pay the United States $125,000 to resolve allegations that he failed to comply with federal statutory requirements related to his role as the Drug Enforcement Administration registrant at Sutter Imaging Capitol Pavilion, Acting U.S. Attorney Michele Beckwith and Drug Enforcement Administration...
Junio 04, 2025
PRESS RELEASE

Honduran National Extradited to the United States for Fentanyl Trafficking

Enero 24, 2025
SACRAMENTO, Calif. — An indictment was unsealed today charging Honduran national Abner Estrada Cruz, 25, with conspiracy to distribute at least 400 grams fentanyl and seven counts of distributing fentanyl, Acting U.S. Attorney Michele Beckwith and Drug Enforcement Administration Special Agent in Charge Bob P. Beris announced. Estrada Cruz was...
Enero 24, 2025
PRESS RELEASE

Justice Department Sues Stockton-based Nurse Practitioner to Stop Her Sale of Illegal Opioid Prescriptions

Enero 14, 2025
SACRAMENTO, Calif. — The United States has filed a civil complaint against nurse practitioner Joan Rubinger, registered in Stockton, that alleges a long-running nationwide scheme to sell illegal opioid prescriptions for cash, Acting U.S. Attorney Michele Beckwith and Drug Enforcement Administration Special Agent in Charge Bob P. Beris announced. The...
Enero 14, 2025
PRESS RELEASE

Alleged Fentanyl Trafficker Extradited from Honduras to Face Charges in San Francisco

Diciembre 20, 2024
SAN FRANCISCO – The government of Honduras extradited Gustavo Erazo, a Honduran national, to the United States this week to appear on charges stemming from his alleged involvement in a conspiracy to distribute fentanyl, heroin, and cocaine in the San Francisco Bay Area. The extradition marks the sixth extradition of...
Diciembre 20, 2024
PRESS RELEASE

Alleged Bay Area Fentanyl Distributor Extradited from Honduras

Octubre 25, 2024
OAKLAND, Calif. – The government of Honduras extradited Javier Marin-Gonzales, a Honduran national, to the United States this week to appear on charges stemming from his alleged involvement in the distribution of fentanyl in the San Francisco Bay Area. The extradition marks the fifth extradition of an alleged drug distributor...
Octubre 25, 2024
PRESS RELEASE

Fourth Honduran National Extradited to the U.S. in Prosecution of Tenderloin District Drug Trafficking Organization

Mayo 09, 2024
SAN FRANCISCO – On May 8, 2024, the government of Honduras extradited convicted felon Victor Viera-Chirinos to the United States. The extradition marks the fourth in the case against 14 defendants alleged to have been trafficking large quantities of heroin, methamphetamine, cocaine base, and cocaine in San Francisco. Information about...
Mayo 09, 2024
PRESS RELEASE

Foreign National Extradited from Mexico to the United States to Face Fentanyl Trafficking Charges

Abril 23, 2024
SACRAMENTO, Calif. — A Mexican national made his initial appearance in federal court in Sacramento on Friday, April 19, 2024, to face charges for fentanyl-pill, cocaine, and methamphetamine trafficking and money laundering, U.S. Attorney Phillip A. Talbert and Drug Enforcement Administration Special Agent in Charge Brian Clark announced. On March...
Abril 23, 2024
PRESS RELEASE

Extradition of Honduran Nationals in Fight Against Fentanyl Trafficking in the Tenderloin District of San Francisco

Febrero 27, 2024
SAN FRANCISCO – U.S. Attorney Ismail J. Ramsey convened a press conference today with Brian Clark, Special Agent in Charge of the Drug Enforcement Administration and Robert K. Tripp, Special Agent in Charge of the Federal Bureau of Investigation, to announce that the government of Honduras extradited three of its...
Febrero 27, 2024
Showing 1 - 10 of 13 results

Paginación

  • Current page 1
  • Página 2
  • Siguiente página ›
  • Última página »
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster